Anthrose-based compositions and related methods
    2.
    发明申请
    Anthrose-based compositions and related methods 审中-公开
    基于Anthrose的组合物和相关方法

    公开(公告)号:US20150265691A1

    公开(公告)日:2015-09-24

    申请号:US11901234

    申请日:2007-09-14

    摘要: This invention provides a vaccine comprising (i) an anthrose-containing saccharide in an amount effective to enhance immunity against Bacillus anthracis in a subject and (ii) a pharmaceutically acceptable carrier. This invention provides a vaccine comprising (i) a conjugate of an anthrose-containing saccharide in an amount effective to enhance immunity against Bacillus anthracis in a subject, wherein the anthrose-containing saccharide is conjugated to a biomolecule via a linker, and (ii) a pharmaceutically acceptable carrier. This invention provides a method for vaccinating a subject against Bacillus anthracis infection comprising administering to the subject a vaccine comprising (i) an anthrose-containing saccharide in an amount effective to enhance immunity against Bacillus anthracis in the subject and (ii) a pharmaceutically acceptable carrier, in an amount effective to stimulate production of antibodies to Bacillus anthracis spores in the subject, thereby vaccinating the subject against Bacillus anthracis.

    摘要翻译: 本发明提供了一种疫苗,其包含(i)含有量的含有糖的糖类,其量有效地增强受试者中对炭疽杆菌的免疫力,和(ii)药学上可接受的载体。 本发明提供了一种疫苗,其包含(i)含有含量的含糖的糖类的缀合物,其有效量以增强受试者中对炭疽芽孢杆菌的免疫力,其中所述含有所述含烟糖的糖通过接头与生物分子缀合,和(ii) 药学上可接受的载体。 本发明提供了一种针对炭疽芽孢杆菌感染接种受试者的方法,其包括向所述受试者施用疫苗,所述疫苗包含(i)含有有效量以提高受试者中对于炭疽杆菌的免疫力的含量的含有糖的糖类,以及(ii)药学上可接受的载体 ,其量有效地刺激在受试者中产生炭疽芽孢杆菌孢子的抗体,从而使受试者接种针对炭疽芽孢杆菌的疫苗。

    TYROSINE LIGATION PROCESS
    3.
    发明申请
    TYROSINE LIGATION PROCESS 有权
    酪氨酸生物过程

    公开(公告)号:US20140141034A1

    公开(公告)日:2014-05-22

    申请号:US14131150

    申请日:2012-07-05

    IPC分类号: A61K47/48

    摘要: A process is provided for preparing a conjugate of Formula (I-A) or (I) comprising a polypeptide containing n number of tyrosine units, where n is an integer greater than or equal to 1, dispersed within the amino acid chain having and amino terminus end (A1) and an acid terminus end (A2) of the protein or polypeptide and having a weight average molecular weight equal to or greater than 10,000 Daltons (10 kDa), wherein the conjugate comprises a number m of tyrosine conjugates (modified tyrosine residues) as depicted in Formula (I-A) or (I), where m is at least one and is less than or equal to n: where X, Lg, L and R are as defined herein.

    摘要翻译: 提供了一种制备式(IA)或(I)的缀合物的方法,其包含分散在具有氨基酸链的氨基酸链和氨基末端末端的含有n个数量的酪氨酸单元的多肽,其中n为大于或等于1的整数 (A1)和所述蛋白质或多肽的酸性末端(A2),并且具有等于或大于10,000道尔顿(10kDa)的重均分子量,其中所述缀合物包含数量m的酪氨酸缀合物(修饰的酪氨酸残基) 如式(IA)或(I)所示,其中m为至少一个且小于或等于n:其中X,Lg,L和R如本文所定义。

    Tyrosine ligation process
    4.
    发明授权
    Tyrosine ligation process 有权
    酪氨酸结扎过程

    公开(公告)号:US09149541B2

    公开(公告)日:2015-10-06

    申请号:US14131150

    申请日:2012-07-05

    摘要: A process is provided for preparing a conjugate of Formula (I-A) or (I) comprising a polypeptide containing n number of tyrosine units, where n is an integer greater than or equal to 1, dispersed within the amino acid chain having and amino terminus end (A1) and an acid terminus end (A2) of the protein or polypeptide and having a weight average molecular weight equal to or greater than 10,000 Daltons (10 kDa), wherein the conjugate comprises a number m of tyrosine conjugates (modified tyrosine residues) as depicted in Formula (I-A) or (I), where m is at least one and is less than or equal to n: where X, Lg, L and R are as defined herein.

    摘要翻译: 提供了一种制备式(IA)或(I)的缀合物的方法,其包含分散在具有氨基酸链的氨基酸链和氨基末端末端的含有n个数量的酪氨酸单元的多肽,其中n为大于或等于1的整数 (A1)和蛋白质或多肽的酸性末端(A2),并且具有等于或大于10,000道尔顿(10kDa)的重均分子量,其中所述缀合物包含数量m的酪氨酸缀合物(修饰的酪氨酸残基) 如式(IA)或(I)所示,其中m为至少一个且小于或等于n:其中X,Lg,L和R如本文所定义。